Biometals in neurodegenerative diseases: mechanisms and therapeutics

Anthony R. White, Michael Aschner, Lucio G. Costa, Ashley I. Bush

Research output: Book/ReportBook

1 Citation (Scopus)

Abstract

Biometals in Neurodegenerative Diseases: Mechanisms and Therapeutics is an authoritative and timely resource bringing together the major findings in the field for ease of access to those working in the field or with an interest in metals and their role in brain function, disease, and as therapeutic targets. Chapters cover metals in Alzheimer's Disease, Parkinson's Disease, Motor Neuron Disease, Autism and lysosomal storage disorders. This book is written for academic researchers, clinicians and advanced graduate students studying or treating patients in neurodegeneration, neurochemistry, neurology and neurotoxicology. The scientific literature in this field is advancing rapidly, with approximately 300 publications per year adding to our knowledge of how biometals contribute to neurodegenerative diseases. Despite this rapid increase in our understanding of biometals in brain disease, the fields of biomedicine and neuroscience have often overlooked this information. The need to bring the research on biometals in neurodegeneration to the forefront of biomedical research is essential in order to understand neurodegenerative disease processes and develop effective therapeutics. Authoritative and timely resource bringing together the major findings in the field for those with an interest in metals and their role in the brain function, disease, and as therapeutic targets Written for academic researchers, clinicians, and advanced graduate students studying, or treating, patients in neurodegeneration, neurochemistry, neurology and neurotoxicology Edited by international leaders in the field who have contributed greatly to the study of metals in neurodegenerative diseases.

Original languageEnglish (US)
PublisherElsevier Inc.
Number of pages451
ISBN (Electronic)9780128045633
ISBN (Print)9780128045626
StatePublished - Apr 28 2017

Fingerprint

Trace Elements
Neurodegenerative Diseases
Brain Diseases
Metals
Neurochemistry
Neurology
Research Personnel
Students
Literature
Motor Neuron Disease
Therapeutics
Neurosciences
Autistic Disorder
Parkinson Disease
Publications
Biomedical Research
Alzheimer Disease
Research

ASJC Scopus subject areas

  • Medicine(all)
  • Neuroscience(all)

Cite this

White, A. R., Aschner, M., Costa, L. G., & Bush, A. I. (2017). Biometals in neurodegenerative diseases: mechanisms and therapeutics. Elsevier Inc.

Biometals in neurodegenerative diseases : mechanisms and therapeutics. / White, Anthony R.; Aschner, Michael; Costa, Lucio G.; Bush, Ashley I.

Elsevier Inc., 2017. 451 p.

Research output: Book/ReportBook

White AR, Aschner M, Costa LG, Bush AI. Biometals in neurodegenerative diseases: mechanisms and therapeutics. Elsevier Inc., 2017. 451 p.
White, Anthony R. ; Aschner, Michael ; Costa, Lucio G. ; Bush, Ashley I. / Biometals in neurodegenerative diseases : mechanisms and therapeutics. Elsevier Inc., 2017. 451 p.
@book{7b055061e3574279bf3df696d5baefe2,
title = "Biometals in neurodegenerative diseases: mechanisms and therapeutics",
abstract = "Biometals in Neurodegenerative Diseases: Mechanisms and Therapeutics is an authoritative and timely resource bringing together the major findings in the field for ease of access to those working in the field or with an interest in metals and their role in brain function, disease, and as therapeutic targets. Chapters cover metals in Alzheimer's Disease, Parkinson's Disease, Motor Neuron Disease, Autism and lysosomal storage disorders. This book is written for academic researchers, clinicians and advanced graduate students studying or treating patients in neurodegeneration, neurochemistry, neurology and neurotoxicology. The scientific literature in this field is advancing rapidly, with approximately 300 publications per year adding to our knowledge of how biometals contribute to neurodegenerative diseases. Despite this rapid increase in our understanding of biometals in brain disease, the fields of biomedicine and neuroscience have often overlooked this information. The need to bring the research on biometals in neurodegeneration to the forefront of biomedical research is essential in order to understand neurodegenerative disease processes and develop effective therapeutics. Authoritative and timely resource bringing together the major findings in the field for those with an interest in metals and their role in the brain function, disease, and as therapeutic targets Written for academic researchers, clinicians, and advanced graduate students studying, or treating, patients in neurodegeneration, neurochemistry, neurology and neurotoxicology Edited by international leaders in the field who have contributed greatly to the study of metals in neurodegenerative diseases.",
author = "White, {Anthony R.} and Michael Aschner and Costa, {Lucio G.} and Bush, {Ashley I.}",
year = "2017",
month = "4",
day = "28",
language = "English (US)",
isbn = "9780128045626",
publisher = "Elsevier Inc.",
address = "United States",

}

TY - BOOK

T1 - Biometals in neurodegenerative diseases

T2 - mechanisms and therapeutics

AU - White, Anthony R.

AU - Aschner, Michael

AU - Costa, Lucio G.

AU - Bush, Ashley I.

PY - 2017/4/28

Y1 - 2017/4/28

N2 - Biometals in Neurodegenerative Diseases: Mechanisms and Therapeutics is an authoritative and timely resource bringing together the major findings in the field for ease of access to those working in the field or with an interest in metals and their role in brain function, disease, and as therapeutic targets. Chapters cover metals in Alzheimer's Disease, Parkinson's Disease, Motor Neuron Disease, Autism and lysosomal storage disorders. This book is written for academic researchers, clinicians and advanced graduate students studying or treating patients in neurodegeneration, neurochemistry, neurology and neurotoxicology. The scientific literature in this field is advancing rapidly, with approximately 300 publications per year adding to our knowledge of how biometals contribute to neurodegenerative diseases. Despite this rapid increase in our understanding of biometals in brain disease, the fields of biomedicine and neuroscience have often overlooked this information. The need to bring the research on biometals in neurodegeneration to the forefront of biomedical research is essential in order to understand neurodegenerative disease processes and develop effective therapeutics. Authoritative and timely resource bringing together the major findings in the field for those with an interest in metals and their role in the brain function, disease, and as therapeutic targets Written for academic researchers, clinicians, and advanced graduate students studying, or treating, patients in neurodegeneration, neurochemistry, neurology and neurotoxicology Edited by international leaders in the field who have contributed greatly to the study of metals in neurodegenerative diseases.

AB - Biometals in Neurodegenerative Diseases: Mechanisms and Therapeutics is an authoritative and timely resource bringing together the major findings in the field for ease of access to those working in the field or with an interest in metals and their role in brain function, disease, and as therapeutic targets. Chapters cover metals in Alzheimer's Disease, Parkinson's Disease, Motor Neuron Disease, Autism and lysosomal storage disorders. This book is written for academic researchers, clinicians and advanced graduate students studying or treating patients in neurodegeneration, neurochemistry, neurology and neurotoxicology. The scientific literature in this field is advancing rapidly, with approximately 300 publications per year adding to our knowledge of how biometals contribute to neurodegenerative diseases. Despite this rapid increase in our understanding of biometals in brain disease, the fields of biomedicine and neuroscience have often overlooked this information. The need to bring the research on biometals in neurodegeneration to the forefront of biomedical research is essential in order to understand neurodegenerative disease processes and develop effective therapeutics. Authoritative and timely resource bringing together the major findings in the field for those with an interest in metals and their role in the brain function, disease, and as therapeutic targets Written for academic researchers, clinicians, and advanced graduate students studying, or treating, patients in neurodegeneration, neurochemistry, neurology and neurotoxicology Edited by international leaders in the field who have contributed greatly to the study of metals in neurodegenerative diseases.

UR - http://www.scopus.com/inward/record.url?scp=85040569699&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040569699&partnerID=8YFLogxK

M3 - Book

AN - SCOPUS:85040569699

SN - 9780128045626

BT - Biometals in neurodegenerative diseases

PB - Elsevier Inc.

ER -